This content is only for use by healthcare professionals.

By continuing to view this content, you are confirming that you are a healthcare professional.

Key Opinion

Five questions about first-line treatment selection every cardiovascular disease team should ask

  • Data normalization
  • Diagnostic imaging workflows
  • Combination therapy
  • High-throughput screening

Date Published:

Abstract

Recent studies suggest that variability between operators remains a key limitation, and this trend is expected to continue. Emerging evidence indicates that pre-analytical factors account for a large share of observed variance, which has direct implications for daily practice.

Contrary to earlier assumptions, variability between operators remains a key limitation, with meaningful differences between subgroups. Emerging evidence indicates that threshold harmonization is still an open question, although confirmatory data are still limited. When protocols are compared, training and accreditation are decisive for reproducibility, and this trend is expected to continue. Across multiple cohorts, cross-disciplinary review changes the initial assessment in a sizeable minority of cases, particularly in resource-constrained settings.

Expert commentary

In routine practice, training and accreditation are decisive for reproducibility, although confirmatory data are still limited. Longitudinal data show that pre-analytical factors account for a large share of observed variance, a finding echoed by several independent groups. In routine practice, threshold harmonization is still an open question, particularly in resource-constrained settings.

When protocols are compared, standardized reporting improves comparability between centers, as discussed in the accompanying commentary. Contrary to earlier assumptions, standardized reporting improves comparability between centers, a finding echoed by several independent groups.

According to consensus recommendations, pre-analytical factors account for a large share of observed variance, and this trend is expected to continue. Longitudinal data show that real-world registries complement randomized trial evidence, with meaningful differences between subgroups.

Limitations

Across multiple cohorts, real-world registries complement randomized trial evidence, pending validation in prospective studies. When protocols are compared, patient selection criteria deserve closer scrutiny, pending validation in prospective studies. In multidisciplinary settings, cross-disciplinary review changes the initial assessment in a sizeable minority of cases, pending validation in prospective studies.

In routine practice, cross-disciplinary review changes the initial assessment in a sizeable minority of cases, although confirmatory data are still limited. Contrary to earlier assumptions, digital tooling shortens time-to-decision considerably, as discussed in the accompanying commentary. When protocols are compared, pre-analytical factors account for a large share of observed variance, and this trend is expected to continue.

Contrary to earlier assumptions, digital tooling shortens time-to-decision considerably, which has direct implications for daily practice. Longitudinal data show that pre-analytical factors account for a large share of observed variance, pending validation in prospective studies. Longitudinal data show that pre-analytical factors account for a large share of observed variance, and this trend is expected to continue.

What the evidence shows

According to consensus recommendations, variability between operators remains a key limitation, particularly in resource-constrained settings. Across multiple cohorts, integrating quantitative measures reduces subjective bias, a finding echoed by several independent groups.

Across multiple cohorts, integrating quantitative measures reduces subjective bias, with meaningful differences between subgroups. When protocols are compared, standardized reporting improves comparability between centers, pending validation in prospective studies. According to consensus recommendations, early intervention correlates with better long-term outcomes, pending validation in prospective studies.

Recent studies suggest that cost considerations continue to shape adoption in smaller units, particularly in resource-constrained settings. Longitudinal data show that standardized reporting improves comparability between centers, particularly in resource-constrained settings.

In multidisciplinary settings, threshold harmonization is still an open question, a finding echoed by several independent groups. Across multiple cohorts, variability between operators remains a key limitation, as discussed in the accompanying commentary.

Open questions

In routine practice, cross-disciplinary review changes the initial assessment in a sizeable minority of cases, pending validation in prospective studies. From a workflow perspective, integrating quantitative measures reduces subjective bias, with meaningful differences between subgroups. When protocols are compared, patient selection criteria deserve closer scrutiny, pending validation in prospective studies. From a workflow perspective, digital tooling shortens time-to-decision considerably, which has direct implications for daily practice. In routine practice, digital tooling shortens time-to-decision considerably, which has direct implications for daily practice.

Contrary to earlier assumptions, variability between operators remains a key limitation, as discussed in the accompanying commentary. Emerging evidence indicates that threshold harmonization is still an open question, as discussed in the accompanying commentary. Recent studies suggest that variability between operators remains a key limitation, pending validation in prospective studies.

Recent studies suggest that standardized reporting improves comparability between centers, pending validation in prospective studies. From a workflow perspective, digital tooling shortens time-to-decision considerably, and this trend is expected to continue. Emerging evidence indicates that cost considerations continue to shape adoption in smaller units, particularly in resource-constrained settings. Recent studies suggest that integrating quantitative measures reduces subjective bias, pending validation in prospective studies.

Key considerations

In multidisciplinary settings, digital tooling shortens time-to-decision considerably, with meaningful differences between subgroups. According to consensus recommendations, variability between operators remains a key limitation, and this trend is expected to continue. Across multiple cohorts, cost considerations continue to shape adoption in smaller units, a finding echoed by several independent groups. Contrary to earlier assumptions, digital tooling shortens time-to-decision considerably, a finding echoed by several independent groups.

Across multiple cohorts, pre-analytical factors account for a large share of observed variance, as discussed in the accompanying commentary. Longitudinal data show that digital tooling shortens time-to-decision considerably, particularly in resource-constrained settings.

References

  1. Haddad et al. Instrument calibration. J Cardiovascular disease Res. 2026;13(11):757-1069.
  2. Tanaka et al. Sample preparation. J Cardiovascular disease Res. 2025;29(10):601-1062.
  3. Okafor et al. Treatment adherence. J Cardiovascular disease Res. 2026;26(2):846-1032.
  4. Okafor et al. Sample preparation. J Cardiovascular disease Res. 2023;43(11):327-1023.